Tandem Diabetes Care Inc (TNDM)
47.23
-0.07
(-0.15%)
USD |
NASDAQ |
May 20, 16:00
50.05
+2.82
(+5.97%)
Pre-Market: 08:45
Tandem Diabetes Care 1 Year Total Returns (Daily): 67.96% for May 20, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 20, 2024 | 67.96% |
May 17, 2024 | 55.54% |
May 16, 2024 | 58.33% |
May 15, 2024 | 47.43% |
May 14, 2024 | 33.71% |
May 13, 2024 | 33.28% |
May 10, 2024 | 33.17% |
May 09, 2024 | 34.63% |
May 08, 2024 | 26.05% |
May 07, 2024 | 25.50% |
May 06, 2024 | 24.07% |
May 03, 2024 | 11.94% |
May 02, 2024 | -5.33% |
May 01, 2024 | -9.43% |
April 30, 2024 | -7.30% |
April 29, 2024 | -6.39% |
April 26, 2024 | -6.03% |
April 25, 2024 | -2.12% |
April 24, 2024 | -4.75% |
April 23, 2024 | -6.70% |
April 22, 2024 | -15.34% |
April 19, 2024 | -26.18% |
April 18, 2024 | -22.15% |
April 17, 2024 | -23.97% |
April 16, 2024 | -20.56% |
Date | Value |
---|---|
April 15, 2024 | -23.21% |
April 12, 2024 | -19.39% |
April 11, 2024 | -20.23% |
April 10, 2024 | -15.58% |
April 09, 2024 | -15.83% |
April 08, 2024 | -19.06% |
April 05, 2024 | -18.14% |
April 04, 2024 | -18.66% |
April 03, 2024 | -13.09% |
April 02, 2024 | -17.51% |
April 01, 2024 | -16.65% |
March 28, 2024 | -12.00% |
March 27, 2024 | -12.67% |
March 26, 2024 | -20.00% |
March 25, 2024 | -28.52% |
March 22, 2024 | -27.01% |
March 21, 2024 | -27.11% |
March 20, 2024 | -21.99% |
March 19, 2024 | -25.13% |
March 18, 2024 | -24.36% |
March 15, 2024 | -32.08% |
March 14, 2024 | -34.16% |
March 13, 2024 | -28.28% |
March 12, 2024 | -20.52% |
March 11, 2024 | -21.50% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-74.00%
Minimum
Nov 03 2022
448.7%
Maximum
May 21 2019
11.86%
Average
10.00%
Median
Oct 06 2021
1 Year Total Returns (Daily) Benchmarks
Insulet Corp | -38.83% |
Abbott Laboratories | -3.32% |
Stryker Corp | 16.72% |
Twist Bioscience Corp | 244.4% |
Perspective Therapeutics Inc | 235.2% |